Viemed Healthcare (VMD) Research & Development (2019 - 2026)
Viemed Healthcare's (VMD) quarterly Research & Development came in at $579000.0 in Q1 2026, down 27.35% YoY from $797000.0 in Q1 2025, and down 3.18% on a QoQ basis from $598000.0 in Q4 2025.
Viemed Healthcare (VMD) Research & Development (2019 - 2026) Analysis & Trends
Viemed Healthcare (VMD) has 8 years of Research & Development data on file, last reported at $579000.0 in Q1 2026.
- Quarterly Research & Development fell 27.35% year-over-year to $579000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 million (down 10.14% YoY) and the FY2025 annual result came in at $3.0 million, down 1.66% from the prior year.
- Research & Development slipped to $579000.0 in Q1 2026, from $598000.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $847000.0 in Q2 2025 to a low of $579000.0 in Q1 2026.
- A 5-year average of $714235.3 and a median of $750000.0 in 2024 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development surged 86.43% — and 2026, when it declined 27.35%.
- Tracing VMD's Research & Development over 5 years: stood at $722000.0 in 2022, then slipped by 9.83% to $651000.0 in 2023, then rose by 23.35% to $803000.0 in 2024, then slipped by 25.53% to $598000.0 in 2025, then fell by 3.18% to $579000.0 in 2026.
- The last three Research & Development figures came in at $579000.0 (Q1 2026), $598000.0 (Q4 2025), and $775000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Viemed Healthcare | 331.59 Mn | 320.91 Mn | 45.05 Mn | 504,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 504,000.00 |
| Mar 31, 2026 | 579,000.00 |
| Dec 31, 2025 | 598,000.00 |
| Sep 30, 2025 | 775,000.00 |
| Jun 30, 2025 | 847,000.00 |
| Mar 31, 2025 | 797,000.00 |
| Dec 31, 2024 | 803,000.00 |
| Sep 30, 2024 | 757,000.00 |
| Jun 30, 2024 | 758,000.00 |
| Mar 31, 2024 | 750,000.00 |
| Dec 31, 2023 | 651,000.00 |
| Sep 30, 2023 | 593,000.00 |
| Jun 30, 2023 | 758,000.00 |
| Mar 31, 2023 | 780,000.00 |
| Dec 31, 2022 | 722,000.00 |
| Sep 30, 2022 | 670,000.00 |
| Jun 30, 2022 | 672,000.00 |
| Mar 31, 2022 | 632,000.00 |
| Dec 31, 2021 | 612,000.00 |
| Sep 30, 2021 | 576,000.00 |